BLUEBIRD BIO INC's ticker is BLUE and the CUSIP is 09609G100. A total of 272 filers reported holding BLUEBIRD BIO INC in Q4 2020. The put-call ratio across all filers is 1.17 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2021 | $372,000 | +78.0% | 11,636 | +140.8% | 0.01% | +75.0% |
Q4 2020 | $209,000 | +0.5% | 4,832 | +25.7% | 0.00% | -20.0% |
Q3 2020 | $208,000 | +4.0% | 3,844 | +17.2% | 0.01% | 0.0% |
Q2 2020 | $200,000 | -11.5% | 3,280 | +84.3% | 0.01% | -16.7% |
Q2 2019 | $226,000 | -19.3% | 1,780 | 0.0% | 0.01% | -14.3% |
Q1 2019 | $280,000 | – | 1,780 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TANG CAPITAL MANAGEMENT LLC | 5,910,687 | $24,470,000 | 3.71% |
Monaco Asset Management SAM | 306,142 | $1,267,000 | 0.55% |
Parametrica Management Ltd | 90,105 | $374,000 | 0.41% |
Kamunting Street Capital Management, L.P. | 55,200 | $229,000 | 0.31% |
Birchview Capital, LP | 98,000 | $406,000 | 0.30% |
Kamunting Street Capital Management, L.P. | 35,000 | $145,000 | 0.20% |
PDT Partners, LLC | 519,477 | $2,151,000 | 0.19% |
Graham Capital Management, L.P. | 781,912 | $3,237,000 | 0.13% |
CAXTON ASSOCIATES LP | 220,154 | $911,000 | 0.09% |
Baker Brothers Advisors | 2,499,715 | $10,349,000 | 0.06% |